
Developing a novel treatment
for ocular Epidermolysis Bullosa
Navigating Epidermolysis Bullosa
Understanding the Challenges and Solution
Epidermolysis Bullosa (EB) is an ultra-rare genetic disorder characterized by fragility of the eyes and skin, making them prone to blistering and tearing from minor friction or trauma. This condition primarily affects children, presenting a lifelong challenge that demands specialized care and attention.​​
​
The ocular manifestations of this condition are profound and painful, and if left unaddressed, they can lead to blindness. Recognizing the pivotal role of ocular health in patient quality of life, we're driven to forge solutions that address this unmet need.
ELK-003
Eye drops for Epidermolysis Bullosa

ELK-003 is an experimental biological drug
currently in a clinical trial for the treatment of ocular manifestations of EB.
